Successful pregnancy depends on well-regulated extravillous trophoblast (EVT) invasion into the uterine decidua and moderate uterine spiral artery remodeling. Ephrin receptor B4 (EPHB4) is a membrane-anchored receptor tyrosine kinase that plays an important role in various cellular functions in human normal tissue and tumors. Reportedly, EPHB4 plays important roles during placentation. Still, there is no investigation of EPHB4 modulating trophoblast function. In our study, term placentas of preeclamptic pregnancies showed a significantly increased EPHB4 expression compared to those of uncomplicated pregnancies (n ¼ 15). Exogenous up-regulation of EPHB4 in HTR-8/SVneo cells was performed to investigate the effects of EPHB4 on cell biological behavior. The results showed that EPHB4 enhancement reduced cell proliferation and promoted trophoblast apoptosis; and inhibited cell migration, invasion, and endothelial replacement. Associated factors, such as matrix metalloproteinases, vascular endothelial growth factor, placental growth factor, and soluble Fms-like tyrosine kinase 1 were examined at transcriptional level. Furthermore, cell functional results were confirmed in a placenta-decidua coculture system, showing poor vascular remodeling. Additionally, we detected possible down-stream PI3K-Akt signal pathway involved in EPHB4-mediated function of HTR-8/SVneo cells. Our study demonstrates that EPHB4 overexpression may contribute to trophoblasts dysfunction and impair maternal artery remodeling, as is associated with the pathogenesis of preeclampsia.
INTRODUCTION
Functional placenta establishment is pivotal for successful fetal development and pregnancy outcomes [1] . During early placentation, trophoblast precursors differentiate into and highly invasive syncytiotrophoblasts and trophoblast subtypes [2] . The latter cell type, referred to as extravillous trophoblasts (EVTs), penetrate the maternal uterus, reaching as far as the inner third of the myometrium. EVTs physiologically interact with maternal immune cells, inducing elastolysis in the arterial wall and replacing the endothelial cells (ECs) lining the spiral arteries to achieve intraluminal vascular remodeling [3, 4] . The uterine spiral arteries are completely transformed into a largeflow and low-resistance conduit, enabling adequate perfusion of the placenta by maternal blood. Aberrant EVT function, superficial invasion, and reduced blood flow to the placenta are related to pregnancy complications like preeclampsia and intrauterine growth retardation [5, 6] . Thus, proper trophoblastmediated uterine spiral artery remodeling is a prerequisite for a healthy human pregnancy, and an improved understanding of the mechanism of human trophoblast invasion may provide therapeutic interventions for pregnancy complications.
Ephrin (EPH) receptors were identified in the late 1980s and are known as the largest family of receptor tyrosine kinases [7] ; EPH is involved in embryonic formation [8] , nervous system development [9] , and angiogenesis [10, 11] . Nine type A glycosylphosphatidylinositol-linked EPH receptors (EPHA1-EPHA8 and EPHA10) and five type-B EPH membraneanchored receptors (EPHB1-EPHB4 and EPHB6) have been identified in mammals [12] . They and their ligands mediate bidirectional signaling pathways and play important roles in regulating cell proliferation, apoptosis, attachment, migration, and invasion [13] [14] [15] . In particular, the expression of EPHB4 and its ligand EFNB2 at the maternal-fetal interface has been shown to modulate endothelium-trophoblast interactions [16, 17] . Reportedly, differences in EPHB4 expression existed in preeclampsia compared to uncomplicated pregnancy [18] . However, the role of EPHB4 in modulating trophoblast function is not fully understood.
In this study, first, we compared the expression of EPHB4 in term preeclamptic placentas to that in controls. Next, we determined the effect of EPHB4 overexpression on trophoblast proliferation, apoptosis, migration, and invasion. We further tested our hypothesis in a trophoblast-endothelium interaction model and a placenta-decidua coculture (PDC) system. Our study results provide a more thorough understanding of defective uterine spiral artery remodeling in preeclampsia.
MATERIALS AND METHODS

Ethics Statement
This study was approved in advance by the Ethics Committee of Union Hospital, Huazhong University of Science and Technology (HUST), Wuhan, China. Written informed consent was obtained from all patients.
Study Population and Tissue Collection
The study was conducted at the Department of Obstetrics and Gynecology, Union Hospital, HUST, Wuhan, China, from October 2014 to February 2015. The study groups consisted of 15 nulliparous women with preeclampsia and 15 nulliparous women with uncomplicated pregnancy. All subjects were in their third trimester of pregnancy and underwent cesarean section. Subjects had routinely provided detailed history and undergone systemic and obstetric examinations, ultrasonographic evaluations, hematology testing, and uterine analyses. Preeclampsia was diagnosed as a systolic blood pressure !140 mm Hg and/or diastolic blood pressure !90 mm Hg after 20 weeks, and proteinuria of .300 mg/24 h in previously normotensive women. The exclusion criteria included tobacco use, history of cardiovascular disease, diabetes mellitus, other severe preexisting metabolic disorders, membrane rupture, fetal anomaly, and multiple pregnancies. After delivery of the placenta, placental specimens were taken from the center area around the umbilical cord attachment site and then washed with sterile phosphate-buffered saline (PBS) and stored in liquid nitrogen for RNA and protein extraction.
Another clinical sample was needed for immunohistochemistry and PDCs. Placental explants, including villous and decidua perietalis tissue, were obtained from patients undergoing elective termination in the first trimester. The precise gestational age was calculated according to the first ultrasonography report of early pregnancy. At 6-9 wk of gestation, tissue was collected in cold PBS and dissected (n ¼ 10). Pregnant women with the following complications were excluded: hypertension, heart disease or other chronic diseases, pregnancy complication history (e.g., preeclampsia), other adverse pregnancy outcomes (e.g., abortion), uterine surgery history, and severe reproductive tract infection. Tissues from 10 pregnant women were collected for immunohistochemistry staining and another 10 for coculture.
In Vitro Transient Transfection pEGFP-EPHB4 and its negative control vector were obtained from Genechem Co., Ltd. The pEGFP-EPHB4 plasmid carries the full-length EPHB4 gene (hereafter referred to as HE). The transient transfection of HTR-8/ SVneo cells was performed using a reagent (Neofect; Bio-technologies) according to the manufacturer's instructions. Briefly, Cells were seeded into 12-well plates, at a total of 1.5 3 10 5 cells per well. When cells reached 80% confluence, they were transfected with 4.0 lg of vector DNA by 4 ll of Neofect reagent in 200 ll of Opti-MEM (Gibco-BRL-Life Technologies). After 24-h transfection, the medium was replaced by RPMI 1640 medium (Gibco-BRL-Life Technologies) supplemented with 10% fetal bovine serum. In vitro transfection efficiency was detected using real-time quantitative PCR (qPCR) and Western blotting. The efficiency of transfection was ;70% for all experimental groups.
RNA Isolation and Real-Time qPCR
Total RNA was extracted from tissue and cells using TRIzol reagent (Invitrogen) and reverse transcribed into complementary DNA (cDNA) using PrimeScript reverse-transcription reagent kit (Takara). PCR amplification was performed in triplicate using the StepOne real-time PCR system (Applied Biosystems, Inc.) under the following conditions: an initial denaturation step (958C for 30 s) and 40 0 Each reaction was performed in triplicate with SYBR Premix Ex Taq (Takara), using 7300 model real-time PCR system (Applied Biosystem). Relative gene expression levels were normalized to b-actin, using the comparative threshold cycle, C t (À2 DDC t ), method.
Western Immunoblotting
Total protein was extracted from tissue or transfected cells by using radioimmunoprecipitation assay buffer, following the manufacturer's protocol. Protein concentrations were measured using the bicinchoninic acid (BCA) method (Beyotime). Total protein (30 lg per sample) was separated by a 12% SDS-PAGE and transferred onto polyvinylidenefluoride membranes. Membranes were blocked with 5% nonfat milk in PBS containing 0.1% Tween-20 to block nonspecific binding for 60 min at room temperature. Membranes were incubated with a rabbit polyclonal anti-human EPHB4 (product AF5271; 1:500 dilution; Affinity), a rabbit monoclonal anti-human PI3K (product 5569), Akt (product 8596), p-Akt (product 4058; 1:2000 dilution; Cell Signaling Technology) overnight at 48C. Mouse monoclonal b-actin (product ab20272; 1:5000 dilution; Abcam) was used as internal control. Membranes were incubated with appropriate secondary antibodies for 1 h at room temperature the next day and visualized with an enhanced chemiluminescence detection system.
Cell Proliferation Assay
Cell proliferation was measured with a cell-counting kit assay (product CCK-8; Beyotime). Transfected cells were seeded into 100 ll of complete culture medium at a density of 1 3 10 4 cells per well on 96-well plates and incubated for 24 h. Then, CCK-8 solution (10 ll per well) was added and incubated for another 2 h, following the manufacturer's instructions. Absorbance was measured at a wavelength of 450 nm.
Annexin V/Propidium Iodide Assay
The Annexin V/propidium iodide assay was used to detect apoptotic cells by flow cytometry according to the manufacturer's instructions. Cells were trypsinized and pelleted by centrifugation at 1000 rpm for 5 min. The pellets were then resuspended in a binding buffer (500 ll). We added 5 ll of Annexin V-fluorescein isothiocyanate and 5 ll of propidium iodide (50 lg/ml) and incubated the pellets at room temperature for 5 min in the dark. Fluorescence intensity was measured using a FACS Calibur flow cytometer (BD Biosciences) and analyzed using software (CellQuest Pro). Cell apoptosis was determined by calculating the total early-to-late apoptosis ratio.
Caspase-3 Colorimetric Assay
The caspase-3 colorimetric assay kit (KeyGEN BioTECH) was used to measure cell apoptosis. Briefly, 200 lg of total extracted protein was diluted in 50 ll of lysis buffer, followed by addition of 23 reaction buffer. Caspase-3 activity was measured with substrate peptides. All samples were incubated at 378C for 4 h in the dark. A microplate reader was used to measure the absorbance at 405 nm. Caspase-3 activity was determined by comparing absorbance levels.
Cell Invasion and Migration Assay
Cell invasion and migration abilities were detected using Transwell assay (pore size 8 lm; Corning). A total of 5 3 10 4 transfected cells were resuspended in serum-free RPMI 1640 medium and added to the upper chamber. Each insert was precoated with 50 ll of Matrigel (BD Biosciences). The lower chamber contained 600 ll of complete culture medium. After incubation for 24 h at 378C in a 5% CO 2 atmosphere, the inserts were fixed in 4% paraformaldehyde and stained with 0.2% crystal violet. Nonmigrating cells were removed from the upper side of the membrane. Migrating cells were counted using an inverted phase-contrast microscope (Olympus) at a magnification of 3200. The average number in five random fields was calculated for each insert. A similar method was applied to the migration assay, except that inserts were not precoated with Matrigel.
Placenta-Decidua Coculture and In Vitro Villous Transfection
A PDC system was established as previously described [19] . Briefly, the coculture dishes (pore size of 8 lm; Corning) were precoated with a total of 0.2 ml phenol red-free Matrigel, which had been diluted 3:1 beforehand with Dulbecco modified Eagle medium/F12 (DMEM/F12) medium containing 10% fetal bovine serum. Thick and intact decidua parietalis were selected and dissected into 2-to 3-mm 2 cubes and placed with the apical epithelial surface uppermost in the lower chamber. Then, patient-matched placental villi (15 mg wet weight) were cut up and placed on the upper chamber in serum-free DMEM/F12 medium containing 200 ll of HE or NC plasmid/liposome 2000 complex, 20 ng/ml progesterone and 300 pg/ml 17b-estradiol. Explants were cultured at 378C in 5% CO 2 . A decidua-only group without corresponding villi was used as empty control to confirm that there was no trophoblast invasion before the establishment of the coculture system and no vascular degradation due to the culture conditions. The culture medium was changed every 48 h, and plasmids were not added. Western blotting was used to detect the transfection efficiency of placental villi. On the sixth day, decidua were fixed and embedded in 4% paraformaldehyde for subsequent immunohistochemical (IHC) detection.
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Trophoblast-Endothelium Coculture
Human umbilical vein ECs (HUVECs; obtained from the Department of Cardiology, Union Hospital, Wuhan, China) were grown on plastic microscope slide coverslips in 6-well plates until confluent and then labeled with 1 lM CMFDA (cell tracker green; Molecular Probes, Inc.) for 2 h. Transfected HTR-8/SVneo cells were labeled with 1 lM CMTPX (cell tracker red; Molecular Probes, Inc.) and then added to the HUVEC monolayer (2 3 10 5 cells/well) and cultured for 24 h. All cocultures were then washed and fixed with 4% paraformaldehyde. Coverslips were mounted onto glass microscope slides and examined using microscopy (IX71 model confocal microscope; Olympus). The area of the HTR-8/SVneo cell ''island'' (red) within the HUVEC monolayer (green) was then quantified by using ImageJ software (U.S. National Institutes of Health; http://imagej.nih.gov/ij). All images were converted to 8-bit gray scale with a defined preset threshold and made into binary images of black and white only. The red ''island'' areas were calculated as the number of pixels, which was used to evaluate HTR-8/SVneo cells' ability to displace HUVECs.
Immunohistochemistry
Paraffin-embedded placental tissues and PDC serial sections were used for IHC. Rehydrated paraffin sections were heated in a citrate buffer (pH, 6.0) for antigen retrieval for 15 min, followed by blockade with 10% normal goat serum for 1 h. Endogenous peroxidase activity was quenched by incubation in 3% H 2 O 2 for 20 min. Sections were incubated for 1 h at room temperature with primary antibody (cytokeratin 7; product MA1024; 1:200 dilution; CD31, PA1950-1; 1:400 dilution; a-SMA, product MA1106, 1:400 dilution; all from Boster; and HLA-G, product AP8941c, 1:800 dilution, from Abgent; and EPHB4, product 14960, 1:500 dilution from Cell Signaling Technology). Slides were incubated for another 30 min with horseradish peroxidaseconjugated immunoglobulin G (IgG; 1:1000 dilution, Santa Cruz Biotechnology). The negative control was processed in the presence of primary antibody neutralized by an excess of synthetic EPHB4 peptide. Then, peroxidase reactivity was detected using a diaminobenzidine substrate kit.
Statistical Analysis
Results are mean 6 SD. Student t-test and ANOVA were used to analyze the data, using Prism version 5 software (GraphPad). A P value ,0.05 was considered statistically significant.
RESULTS
EPHB4 Expression and Localization in Human Preterm Placentas From Both Preeclampsia and Uncomplicated Pregnancies
The subjects' clinical characteristics are listed in Table 1 . Maternal or gestation age in the preeclampsia group showed no significant differences from that in the normal pregnancy group (P . 0.05). To investigate the EPHB4 level in preeclampsia, we detected EPHB4 expression in 15 placental tissue samples from women with preeclampsia and in samples from women with uncomplicated pregnancies by using IHC, PCR, and Western blotting. Notably, as shown in Figure 1A , an IHC analysis of placental sections revealed that EPHB4 labeling in preeclampsia was significantly enhanced compared to that of controls, both EPHB4 mRNA and protein expression showed a similar trend as well (Fig. 1, B and C) .
Location of EPHB4 Expression in Human First-Trimester Villi and Decidua
We examined EPHB4 distribution in human placental tissues of early gestation by using IHC. Immunoreactivity to cytokeratin 7 was used to identify trophoblasts in villi and maternal decidua (Fig. 2, A and D) . The trophoblasts in firsttrimester placental villi exhibited relatively strong membrane EPHB4 immunoreactivity (Fig. 2B) . We observed almost no EPHB4 staining in EVTs, but the venous ECs were EPHB4-positive in decidua (Fig. 2E) . Negative controls are shown in Figure 2 , C and F.
EPHB4 Overexpression in Transfected HTR-8/SVneo cells and the Effect of EPHB4 on Cell Proliferation and Apoptosis
The significant elevation of EPHB4 expression in preeclampsia samples prompted us to explore the possible biological influence of EPHB4 in preeclampsia. We used a DNA plasmid to establish an EPHB4 over-expression model in HTR-8/SVneo cells. Transfection efficiency was detected by real-time qPCR (Fig. 3A) and Western blotting (Fig. 3, B and C). Over-expression of EPHB4 reduced cell proliferation and promoted cell apoptosis in HTR-8/SVneo cells. The proliferation ratio was distinctly decreased after EPHB4 up-regulation in HTR-8/SVneo cells compared to that in negative controls (Fig. 3D) , whereas EPHB4 up-regulation in HTR-8/SVneo cells led to an increased relative rate of apoptotic cells (Fig. 3,  E and F) . Furthermore, caspase-3 colorimetric assay exhibited a higher absorbance (Fig. 3G) , indicating higher caspase-3 activity in HTR-8/SVneo cells with EPHB4 overexpression.
Effects of EPHB4 on Cell Invasion and Migration
Enhanced EPHB4 expression suppressed HTR-8/SVneo migration (Fig. 4A) and invasion (Fig. 4B) . Next, the transcriptional levels of MMP-2 and MMP-9 were detected (Fig. 4C ). MMP-2 transcriptional level was dramatically decreased in HTR-8/SVneo cells following treatment with an EPHB4 overexpression plasmid. The relative mRNA expression levels of MMP-9 did not significantly differ from those of negative control samples. EPHB4 overexpression in HTR-8/SVneo cells led to a significant reduction of red ''island'' area within green HUVEC monolayers, implying that up-regulation of EPHB4 in HTR-8/SVneo cells damaged its ability to displace HUVECs (Fig. 5, A and B) . Endothelial replacement of trophoblasts has a close association with levels of VEGF-A, PlGF, and sFlt-1. Real-time PCR analysis showed overexpression of EPHB4 significantly suppressed the expression of VEGF-A at the transcriptional level (Fig. 5C ), while the reduced PlGF mRNA expression and increased sFlt-1 transcriptional level in HTR-8/ SVneo cells revealed no statistical differences (Fig. 5, D and F).
Up-Regulation of EPHB4 Impairs Maternal Artery Remodeling
A PDC system was established to further investigate the effects of EPHB4 up-regulation. At the site of placenta-decidua contact, trophoblasts arising from the tips of villi attached to the decidual epithelial surface and invaded the maternal decidua. Then, vascular change occurred and eventually was replaced by endovascular extravillous trophoblasts. Herein, we set a decidua-only group as empty control, which showed an absence of EVTs and exhibited intact vessels with signs of multiple vascular smooth muscle cells (VSMC) layer and EC layer (Fig. 6, A-C) . These unremodeled arteries ensured experimental conditions at the same baseline. The negative control group exhibited active remodeling, which featured the emergence of mounting EVTs, EC desquamation, and a thin layer of VSMCs with disorganization (Fig. 6, D-F) , whereas a less active remodeling was revealed in EPHB4 overexpression group compared with the negative control group (Fig. 6, G-I ). Glands and veins should be distinguished from EVTs and arteries in deciduas, respectively (Fig. 6, J-L) . Therefore, after coculture for 6 days, EPHB4 overexpression group showed poor invasion and less advanced remodeling than negative control. However, few endothelial EVTs were observed in all groups.
EPHB4 Inhibits Phosphatidylinositol-3-Kinase-Akt Signaling Axis
Phosphatidylinositol-3-kinase (PI3K)-Akt signaling pathway plays essential roles in cellular proliferation, differentiation, invasion, and angiogenesis, which have been reported to be downstream targets of EPHB4 receptor signal. We next directly analyzed PI3K-Akt expression in trophoblasts transfected with EPHB4 hyperexpression and negative control plasmid. The mRNA levels of PI3K and Akt in HTR8/SVneo cells of EPHB4 overexpression were decreased by 93% and 40%, respectively, compared with those of the negative control (Fig. 7A) . Western blotting revealed a significant reduction of PI3K, Akt, and p-Akt protein expression in EPHB4 overexpression group compared with those in the negative control (Fig. 7, B and C) .
DISCUSSION
EPHB4 has been shown to be critical for embryonic development [20] , vasculature remodeling [21] , and angiogenesis [11, 22] , which illustrates the important role of this receptor in modulating cell function. Because EPHB4 is also expressed in early gestation mammalian placenta [23] , we speculated that EPHB4 might be involved in the regulation of trophoblast function during placentation. Our study investigated the effect of EPHB4 on biological function of trophoblasts. The main findings are as follows: 1) the levels of EPHB4 in A) The mRNA expression of EPHB4 in the NC group showed no significant differences from that in control but was distinctively increased in the HE group. B) Representative Western blots of EPHB4 protein expression are shown. C) Quantitative analysis showed the protein expression of EPHB4 in the HE group was significantly up-regulated compared to that in the NC group, and was not significantly different from that in controls. HE group ¼ EPHB4 overexpression; NC group ¼ negative control to HE group. D) CCK-8 assay showed that relative proliferation rate was reduced in the HE group compared to that in NC group (0.5971 6 placenta were higher in preeclampsia group than normal, 2) EPHB4 impaired trophoblasts proliferation, migration and invasion and enhanced apoptosis, contributing to poor vascular remodeling and endothelial replacement, and 3) the mechanism of EPHB4 acting on trophoblasts may be through PI3K-Akt signal pathway.
We first analyzed the expression of EPHB4 in term placentas, finding significantly higher levels in 15 human preeclamptic placentas than in placentas from uncomplicated pregnancy controls. This result was in agreement with previous research [16, 18] . Admittedly, it would be more interesting to study preterm preeclampsia rather than term preeclampsia as this subtype of the disorder is associated with more dramatic spiral artery remodeling changes. However, in clinical practice, most preeclampsia can often sustain pregnancy up to or more than 37 wk. Thus, it is difficult to obtain enough preterm preeclampsia placenta samples. In addition, we had no access to placenta samples of different gestational ages to know dynamic EPHB4 expression due to limitations in clinical treatment and ethics requirements, which may be a defect in our study. Nevertheless, from the perspective of the subcellular localization of EPHB4, the expression of EPHB4 in EVTs showed a distinct decrease compared to trophoblasts in villi. We speculate EPHB4 may be down-regulated when trophoblasts in villi differentiate into extravillous trophoblasts. As proven, during human pregnancy, the expression of EPHB4 in trophoblasts is significantly decreased with the gestation stage and is involved in building the functional placental structure 0.07770 vs. 0.9709 6 0.03304, respectively). E and F) HE group showed a significant increase in relative ratio of apoptotic cells compared to that in the NC group, as shown by flow cytometry (18.28 6 2.197 vs. 5.805 6 0.4928, respectively). G) Caspase-3 colorimetric assay showed relative absorbance rate was significantly elevated in HE group compared to that in NC group (1.558 6 0.1006 vs. 1.015 6 0.03690, respectively). *P , 0.05; **P , 0.01; ***P , 0.001 by Student t-test. Data were from triplicate samples of three independent experiments. EPHB4 AND TROPHOBLAST DYSFUNCTION IN PREECLAMPSIA [24] . Therefore, it could be reasonably inferred that EPHB4 upregulation in preeclamptic placentas may be attributed to abnormally increased EPHB4 expression in trophoblasts and its adverse effect on trophoblasts function.
To further investigate the role of EPHB4 in trophoblast HTR-8/SVneo cells, we transfected a hyperexpression plasmid into HTR-8/SVneo cells and then examined the effects on cell function. Enhanced EPHB4 expression significantly reduced trophoblast proliferation, promoted cell apoptosis, and inhibited cell migration and invasion. The related mechanism modulating cell function is complex. Caspase-3 is a mitochondria-dependent apoptosis biomarker [25] , expression of which was induced by up-regulation of EPHB4 in HTR-8/SVneo cells. MMPs play important roles in trophoblast migration and invasion [26, 27] . Multiple levels of MMP regulation have been elucidated, including mRNA expression, protein production, secretion, activation, localization, and degradation [28] . In our study, we focused on its transcriptional level. Our study showed that overexpression of EPHB4 down-regulated MMP-2 expression but had no significant impact on MMP-9 at the transcriptional level, which is in line with the research of Staun-Ram et al. [29] . Taken together, EPHB4 up-regulation in LIU ET AL.
HTR-8/SVneo cells accelerated cell apoptosis and inhibited migration and invasion. As we know, endovascular trophoblast replacement is another crucial process of spiral artery remodeling, which is consequent to interaction of trophoblasts with various cells in decidua spiral artery, especially ECs [30] . Therefore, trophoblast-endothelium coculture system was used to mimic endovascular trophoblast replacement in our study. After EPHB4 up-regulation in HTR-8/SVneo cells, less endothelial replacement was observed. As is known, balance of angiogenic factors (such as VEGF-A and PlGF) and antiangiogenic factors (sFlt-1) produced by trophoblasts are of great value during placentation [31] [32] [33] . Excessive sFlt-1 antagonizes both VEGF-A and PlGF, resulting in placental vessel dysfunction and systemic/local endothelial dysfunction, which is strongly associated with the pathogenesis of preeclampsia [34] . We further investigated the expression of VEGF-A, PlGF, and sFlt-1 in HTR-8/SVneo cells. A distinct reduction in VEGF-A mRNA expression after up-regulation of EPHB4 was observed, whereas the transcription level of PlGF and sFlt-1 showed a decreased and elevated trend, respectively, but had no significant difference between the overexpression group and negative control. Therefore, less endothelial replacement by trophoblasts with EPHB4 overexpression may be due mainly to decreased VEGF-A expression. Consistent results were verified ex vivo in maternal spiral artery remodeling. After up-regulation of EPHB4 in villi, the PDC model showed inadequate trophoblast invasion and incomplete vasculature changes. Although some shortcomings existed in the 3D coculture model, few endovascular EVT replacements were observed. This may have been due to Next, we focused on PI3K signal pathway to explore the possible downstream mechanism of EPHB4 modulating trophoblast function. PI3K-Akt is a common pathway in the differentiation and invasion of trophoblasts [35] [36] [37] . Previous research has indicated that EPHB4 receptor signaling mediates EC migration and proliferation via the PI3K pathway [14] , and an EPHB4 inhibitor could suppress the PI3K signaling pathway [38] . However, our study showed that EPHB4 enhancement impaired trophoblasts function possibly via suppressing PI3K signaling pathway. This inconsistency may attribute to the complicated mechanism of bidirectional signal pathways mediated by EPHB4 and its ligand, which can result in opposite biological effect [39] . Further mechanism study remains to be explored.
Findings regarding the upstream stimulation of EPHB4 will improve our understanding of the role of EPHB4 in trophoblasts during placenta development and our comprehension of its causal relationship with EPHB4 highly expressed in preeclampsia. As is known, early pregnancy was characterized by placenta hypoxia. Several conflicts in experimental evidence demonstrated that physiological hypoxia of early pregnancy promoted the switch of trophoblast phenotype from proliferative to invasive type [40, 41] and that EPHB4 expression is down-regulated. Until term, EPHB4 is hardly expressed [17, 42] . Actually, hypoxia seemed to emerge as a double-edged sword. On the other hand, excessive placental hypoxia can result in altered gene expression and aberrant trophoblast phenotype [43] . Coincidentally, hypoxia was shown to induce the expression of EPHB4 up-regulated under some conditions [21, 44] . EPHB4, intensively expressed in trophoblast damaged cell viability, led to inadequate vascular remodeling and, in turn, aggravated placenta hypoxia. This vicious cycle may explain why EPHB4 expression was elevated in preeclamptic placenta.
Another limitation of our study was the use of the transformed trophoblast cell line HTR-8/SVneo cells. They may not replace primary trophoblasts completely, given that HTR-8/SVneo cells respond to hypoxia differently from primary trophoblasts [43] . It would be more persuasive to adopt primary trophoblasts. However, regardless of hypoxic condition, we exogenously transfected plasmids to evaluate its effects on HTR-8/SVneo cells in our work. To some extent, our study demonstrated the role of EPHB4 in the biological function of trophoblasts and indicated that it may negatively regulate trophoblast-dependent maternal spiral artery remodeling. Therefore EPHB4 may become a potential new target for placental vascular disorders.
